Cargando…

Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty

PURPOSE: We evaluated the efficacy, safety and psychological aspect of monthly administrations of the gonadotropin-releasing hormone agonists (GnRHa), leuprolide acetate depot (Luphere depot 3.75 mg), in patients with precocious puberty. METHODS: A total of 54 girls with central precocious puberty w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, You Jin, Lee, Hae Sang, Lee, Young Jun, Lim, Jung Sub, Kim, Se Young, Kim, Eun Young, Jin, Dong Kyu, Hwang, Il Tae, Hwang, Jin Soon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pediatric Endocrinology 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027087/ https://www.ncbi.nlm.nih.gov/pubmed/24904873 http://dx.doi.org/10.6065/apem.2013.18.4.173

Ejemplares similares

Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
por: Neely, E. Kirk, et al.
Publicado: (2010)

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?
por: Vurallı, Doğuş, et al.
Publicado: (2020)

Efficacy of Leuprorelin 3-Month Depot (11.25 mg) Compared to 1-Month Depot (3.75 mg) for Central Precocious Puberty in Chinese Girls: A Prospective Cohort Study
por: Yang, Jianmei, et al.
Publicado: (2022)

Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study
por: Klein, Karen O, et al.
Publicado: (2023)

Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study
por: Lee, Peter A, et al.
Publicado: (2011)

Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
por: Chung, Lindsey Yoojin, et al.
Publicado: (2021)

Clinical development of the GnRH agonist leuprolide acetate depot
por: Chwalisz, Kristof
Publicado: (2022)

Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty
por: Omar, Anjumanara Anver, et al.
Publicado: (2020)

Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer
por: Spitz, A, et al.
Publicado: (2012)

Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty
por: Jeon, Min Jin, et al.
Publicado: (2021)

Effectiveness of a 6-Month 22.5-mg Leuprolide Acetate Depot Formulation With Tamoxifen for Postoperative Premenopausal Estrogen Suppression in Hormone Receptor-Positive Breast Cancer
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen
por: Lee, Young-jin, et al.
Publicado: (2020)

Pelvic Ultrasound Parameters of Long-Acting Depot Formulation of Leuprorelin in the Treatment of Idiopathic Central Precocious Puberty in Girls
por: Yang, Kun, et al.
Publicado: (2021)

Associations between serum vitamin D levels and precocious puberty in girls
por: Lee, Hae Sang, et al.
Publicado: (2014)

Psychosocial Aspects in Girls with Idiopathic Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2012)

6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty
por: Eugster, Erica A, et al.
Publicado: (2021)

The effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysis
por: Wang, Lan, et al.
Publicado: (2021)

THU198 Peripheral Precocious Puberty In Girls Due To Ovarian Cyst
por: Lee, Hae Sang, et al.
Publicado: (2023)

Thyroid function in girls with central precocious puberty
por: Jung, Geehae, et al.
Publicado: (2019)

Genetic factors in precocious puberty
por: Shim, Young Suk, et al.
Publicado: (2021)

Effect of triptorelin 3.75 mg subcutaneously injection every 6 weeks on adult height in girls with idiopathic central precocious puberty
por: Liang, Yan, et al.
Publicado: (2015)

Prevalence of Pathological Brain Lesions in Girls with Central Precocious Puberty: Possible Overestimation?
por: Yoon, Jong Seo, et al.
Publicado: (2018)

LIN28B polymorphisms are associated with central precocious puberty and early puberty in girls
por: Park, Sung Won, et al.
Publicado: (2012)

The Diagnostic Value of Pelvic Ultrasound in Girls with Central Precocious Puberty
por: Lee, Sang Heon, et al.
Publicado: (2016)

The characteristics of familial precocious puberty
por: Jeong, Hwal Rim, et al.
Publicado: (2015)

Usefulness of pelvic ultrasonography for the diagnosis of central precocious puberty in girls
por: Yu, Jung, et al.
Publicado: (2015)

Myopic Progression in Girls with Gonadotrophin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Chung, Seung Ah, et al.
Publicado: (2021)

A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone(®) 3.75 mg in healthy male subjects
por: Hu, Xingjiang, et al.
Publicado: (2022)

Precocious puberty in girls
por: Chittwar, Sachin, et al.
Publicado: (2012)

Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015)

Diagnosis and constitutional and laboratory features of Korean girls referred for precocious puberty
por: Kim, Doosoo, et al.
Publicado: (2012)

Serum osteocalcin levels in girls with central precocious puberty
por: Rhie, Young Jun, et al.
Publicado: (2013)

KISS1 Gene Polymorphisms in Korean Girls with Central Precocious Puberty
por: Rhie, Young-Jun, et al.
Publicado: (2014)

Serum Kisspeptin Levels in Korean Girls with Central Precocious Puberty
por: Rhie, Young Jun, et al.
Publicado: (2011)

The Assessment of Brain Volume Differences in Idiopathic Central Precocious Puberty Girls; Comparison of Age-Matched Girls and Normal Puberty Girls
por: Park, Shin-Eui, et al.
Publicado: (2021)

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty
por: Klein, Karen O, et al.
Publicado: (2020)

Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
por: Wiromrat, Pattara, et al.
Publicado: (2019)

Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty
por: Cho, Ah Young, et al.
Publicado: (2023)

A Case of a Girl with Arnold-Chiari Type 1 Malformation with Precocious Puberty
por: Kim, Min Sun, et al.
Publicado: (2018)

An 11-month-old girl with central precocious puberty caused by hypothalamic hamartoma
por: Yoon, Da Young, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mvi3bbsn68k7t74d49ckfr9rdh